Rui Tang, Emily G. Shuldiner, Marcus Kelly, Christopher W. Murray, Jess D. Hebert, Laura Andrejka, Min K. Tsai, Nicholas W. Hughes, Mitchell I. Parker, Hongchen Cai, Yao-Cheng Li, Geoffrey M. Wahl, Roland L. Dunbrack, Peter K. Jackson, Dmitri A. Petrov & Monte M. Winslow. (2023) Multiplexed screens identify RAS paralogues HRAS and NRAS as suppressors of KRAS-driven lung cancer growth. Nature Cell Biology 25:1, pages 159-169.
Crossref
Martha Dillon, Antonio Lopez, Edward Lin, Dominic Sales, Ron Perets & Pooja Jain. (2021) Progress on Ras/MAPK Signaling Research and Targeting in Blood and Solid Cancers. Cancers 13:20, pages 5059.
Crossref
Konsta Kukkonen, Sinja Taavitsainen, Laura Huhtala, Joonas Uusi-Makela, Kirsi J. Granberg, Matti Nykter & Alfonso Urbanucci. (2021) Chromatin and Epigenetic Dysregulation of Prostate Cancer Development, Progression, and Therapeutic Response. Cancers 13:13, pages 3325.
Crossref
Chang Woo Han, Mi Suk Jeong & Se Bok Jang. (2021) Understand KRAS and the Quest for Anti-Cancer Drugs. Cells 10:4, pages 842.
Crossref
Kayla R. Kulhanek, Jeroen P. Roose & Ignacio Rubio. 2021. Ras Activity and Signaling. Ras Activity and Signaling
19
43
.
Sonia Rodríguez-Fdez, L. Francisco Lorenzo-Martín, Isabel Fernández-Pisonero, Begoña Porteiro, Christelle Veyrat-Durebex, Daniel Beiroa, Omar Al-Massadi, Antonio Abad, Carlos Diéguez, Roberto Coppari, Rubén Nogueiras & Xosé R. Bustelo. (2020) Vav2 catalysis-dependent pathways contribute to skeletal muscle growth and metabolic homeostasis. Nature Communications 11:1.
Crossref
Sonia Rodríguez-Fdez, Carmen Citterio, L. Francisco Lorenzo-Martín, Jesús Baltanás-Copado, Clara Llorente-González, Senena Corbalán-García, Miguel Vicente-Manzanares & Xosé R. Bustelo. (2019) Phosphatidylinositol Monophosphates Regulate Optimal Vav1 Signaling Output. Cells 8:12, pages 1649.
Crossref
Diva S. Whalen, Sarrah E. Widatalla, Olga Y. Korolkova, Gladys S. Nangami, Heather K. Beasley, Stephen D. Williams, Carlos Virgous, Brian D. Lehmann, Josiah Ochieng & Amos M. Sakwe. (2019) Implication of calcium activated RasGRF2 in Annexin A6-mediated breast tumor cell growth and motility. Oncotarget 10:2, pages 133-151.
Crossref
Timokratis Karamitros, Tara Hurst, Emanuele MarchiEirini KaramichaliUrania GeorgopoulouAndreas MentisJoey RiepsaameAudrey LinDimitrios ParaskevisAngelos HatzakisJohn McLauchlan, Aris KatzourakisGkikas Magiorkinis. (2018)
Human Endogenous Retrovirus-K HML-2 integration within
RASGRF2
is associated with intravenous drug abuse and modulates transcription in a cell-line model
. Proceedings of the National Academy of Sciences 115:41, pages 10434-10439.
Crossref
Arunakumar Gangaplara, Craig Martens, Eric Dahlstrom, Amina Metidji, Ameya S. Gokhale, Deborah D. Glass, Maria Lopez-Ocasio, Rachel Baur, Kishore Kanakabandi, Stephen F. Porcella & Ethan M. Shevach. (2018) Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment. PLOS Pathogens 14:4, pages e1006985.
Crossref
Carmela Gómez, David Jimeno, Alberto Fernández-Medarde, Rósula García-Navas, Nuria Calzada & Eugenio Santos. (2017) Ras-GRF2 regulates nestin-positive stem cell density and onset of differentiation during adult neurogenesis in the mouse dentate gyrus. Molecular and Cellular Neuroscience 85, pages 127-147.
Crossref
Aditi Shendre, Howard Wiener, Marguerite R. Irvin, Degui Zhi, Nita A. Limdi, Edgar T. Overton, Christina L. Wassel, Jasmin Divers, Jerome I. Rotter, Wendy S. Post & Sadeep Shrestha. (2017) Admixture Mapping of Subclinical Atherosclerosis and Subsequent Clinical Events Among African Americans in 2 Large Cohort Studies. Circulation: Cardiovascular Genetics 10:2.
Crossref
Ru Feng WuChengxu LiaoHadi HatoumGuosheng FuCristhiaan D. OchoaLance S. Terada. (2017) RasGRF Couples Nox4-Dependent Endoplasmic Reticulum Signaling to Ras. Arteriosclerosis, Thrombosis, and Vascular Biology 37:1, pages 98-107.
Crossref
Bin Pan, Xiangmin Wang, Shinsuke Kojima, Chie Nishioka, Akihito Yokoyama, Goichi Honda, Kailin Xu & Takayuki Ikezoe. (2017) The fifth epidermal growth factor like region of thrombomodulin alleviates LPS-induced sepsis through interacting with GPR15. Thrombosis and Haemostasis 117:03, pages 570-579.
Crossref
David Jimeno, Carmela Gómez, Nuria Calzada, Pedro de la Villa, Concepción Lillo & Eugenio Santos. (2016) RasGRF2 controls nuclear migration in postnatal retinal cone photoreceptors. Journal of Cell Science.
Crossref
Virginia Ojeda, Javier Robles-Valero, María Barreira & Xosé R. Bustelo. (2015) The disease-linked Glu-26-Lys mutant version of Coronin 1A exhibits pleiotropic and pathway-specific signaling defects. Molecular Biology of the Cell 26:16, pages 2895-2912.
Crossref
Anne Hennig, Robby Markwart, Manuel A. Esparza-Franco, Graham Ladds & Ignacio Rubio. (2015) Ras activation revisited: role of GEF and GAP systems. Biological Chemistry 396:8, pages 831-848.
Crossref
D R Cook, K L Rossman & C J Der. (2013) Rho guanine nucleotide exchange factors: regulators of Rho GTPase activity in development and disease. Oncogene 33:31, pages 4021-4035.
Crossref
María BarreiraSalvatore FabbianoJosé R. CouceiroEva TorreiraJorge L. Martínez-TorrecuadradaGuillermo MontoyaOscar LlorcaXosé R. Bustelo. (2014) The C-Terminal SH3 Domain Contributes to the Intramolecular Inhibition of Vav Family Proteins. Science Signaling 7:321.
Crossref
Olga Ksionda, Andre Limnander & Jeroen P. Roose. (2013) RasGRP Ras guanine nucleotide exchange factors in cancer. Frontiers in Biology 8:5, pages 508-532.
Crossref
Robert L. Kortum, Alexandre K. Rouquette-Jazdanian & Lawrence E. Samelson. (2013) Ras and extracellular signal-regulated kinase signaling in thymocytes and T cells. Trends in Immunology 34:6, pages 259-268.
Crossref
Marc ThirietMarc Thiriet. 2013. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems
465
646
.
Marc ThirietMarc Thiriet. 2013. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems
387
463
.
Marc ThirietMarc Thiriet. 2013. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems
379
386
.
Marc ThirietMarc Thiriet. 2013. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems
311
378
.
Marc ThirietMarc Thiriet. 2013. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems
175
310
.
Marc ThirietMarc Thiriet. 2013. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems
137
173
.
Marc ThirietMarc Thiriet. 2013. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems
109
135
.
Marc ThirietMarc Thiriet. 2013. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems
7
107
.
Marc ThirietMarc Thiriet. 2013. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems
911
918
.
Marc ThirietMarc Thiriet. 2013. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems
821
909
.
Marc ThirietMarc Thiriet. 2013. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems. Intracellular Signaling Mediators in the Circulatory and Ventilatory Systems
647
819
.
Christine E. Gilling, Amit K. Mittal, Nagendra K. Chaturvedi, Javeed Iqbal, Patricia Aoun, Philip J. Bierman, Robert G. Bociek, Dennis D. Weisenburger & Shantaram S. Joshi. (2012) Lymph node-induced immune tolerance in chronic lymphocytic leukaemia: a role for caveolin-1. British Journal of Haematology 158:2, pages 216-231.
Crossref
Saswati Mahapatra, Eric W. Klee, Charles Y.F. Young, Zhifu Sun, Rafael E. Jimenez, George G. Klee, Donald J. Tindall & Krishna Vanaja Donkena. (2012) Global Methylation Profiling for Risk Prediction of Prostate Cancer. Clinical Cancer Research 18:10, pages 2882-2895.
Crossref
Nicole Warnecke, Mateusz Poltorak, Bhavani S Kowtharapu, Boerge Arndt, James C Stone, Burkhart Schraven & Luca Simeoni. (2012) TCR‐mediated Erk activation does not depend on Sos and Grb2 in peripheral human T cells. EMBO reports 13:4, pages 386-391.
Crossref
James W. Dennis & Ivan R. Nabi. 2011. Cellular Domains. Cellular Domains
133
146
.
Robert L. KortumConnie L. SommersClayton P. AlexanderJohn M. PinskiWenmei LiAlex Grinberg, Jan Lee, Paul E. Love & Lawrence E. Samelson. (2011) Targeted Sos1 deletion reveals its critical role in early T-cell development. Proceedings of the National Academy of Sciences 108:30, pages 12407-12412.
Crossref
Fernando Calvo, Victoria Sanz-Moreno, Lorena Agudo-Ibáñez, Fredrik Wallberg, Erik Sahai, Christopher J. Marshall & Piero Crespo. (2011) RasGRF suppresses Cdc42-mediated tumour cell movement, cytoskeletal dynamics and transformation. Nature Cell Biology 13:7, pages 819-826.
Crossref
Alberto Fernández-Medarde & Eugenio Santos. (2011) The RasGrf family of mammalian guanine nucleotide exchange factors. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1815:2, pages 170-188.
Crossref
Xose Bustelo. (2010) Vav1. AfCS-Nature Molecule Pages.
Crossref
Ignacio Rubio, Stefan Grund, Shu-Ping Song, Christoph Biskup, Sabine Bandemer, Melanie Fricke, Martin Förster, Andrea Graziani, Ute Wittig & Stefanie Kliche. (2010) TCR-Induced Activation of Ras Proceeds at the Plasma Membrane and Requires Palmitoylation of N-Ras. The Journal of Immunology 185:6, pages 3536-3543.
Crossref
Lydia Ng, Chris Lau, Susan M. Sunkin, Amy Bernard, M. Mallar Chakravarty, Ed S. Lein, Allan R. Jones & Michael Hawrylycz. (2010) Surface-based mapping of gene expression and probabilistic expression maps in the mouse cortex. Methods 50:2, pages 55-62.
Crossref
Fernando Calvo & Piero Crespo. (2009) Structural and Spatial Determinants Regulating TC21 Activation by RasGRF Family Nucleotide Exchange Factors. Molecular Biology of the Cell 20:20, pages 4289-4302.
Crossref
Ashok PrasadJulie Zikherman, Jayajit DasJeroen P. RooseArthur Weiss & Arup K. Chakraborty. (2009) Origin of the sharp boundary that discriminates positive and negative selection of thymocytes. Proceedings of the National Academy of Sciences 106:2, pages 528-533.
Crossref
Lucas Fernández-Campo, María T. Grande, Julia Diego, Isabel Fuentes-Calvo, Juan F. Macías-Núñez, Angel Sánchez-Rodríguez, Jesús Grande, Luis García-Ortiz, José M. López-Novoa & Carlos Martínez-Salgado. (2008) Effect of different antihypertensive treatments on Ras, MAPK and Akt activation in hypertension and diabetes. Clinical Science 116:2, pages 165-173.
Crossref
Jayajit Das, Mary Ho, Julie Zikherman, Christopher Govern, Ming Yang, Arthur Weiss, Arup K. Chakraborty & Jeroen P. Roose. (2009) Digital Signaling and Hysteresis Characterize Ras Activation in Lymphoid Cells. Cell 136:2, pages 337-351.
Crossref
Eugene Santos & Alberto Fernández-Medarde. (2008) Rasgrf2. AfCS-Nature Molecule Pages.
Crossref
Sergio Ruiz, Antonio Castro-Castro & Xosé R. Bustelo. (2008) CD147 Inhibits the Nuclear Factor of Activated T-cells by Impairing Vav1 and Rac1 Downstream Signaling. Journal of Biological Chemistry 283:9, pages 5554-5566.
Crossref